Japan Results Roundup: Strong Mainstays, Currency Windfall Help Top Line

 
• By Lisa Takagi
Major Japanese pharmaceutical firms' Q2 performance was largely supported by their US performance with weak forex rate.
Major Japan pharma firms' Q1 performance supported by global performance, weak yen • Source: Shutterstock

More from Japan

More from Focus On Asia